Differentiation of SWO-38 glioma cells induced by CDA-2 is mediated by peroxisome proliferator-activated receptor γ

Journal of Neuro-Oncology

Volumn 95, Issue 1, 2009, Pages 29-36

  Lin, Chen Li ^a   Wang, Ming Hua ^b   Qin, Yan Fang ^a   Fang, Mao ^a   Xie, Bin Bin ^a   Zhong, Xue Yun ^a  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b HAINAN MEDICAL UNIVERSITY   (China)

Author keywords

COX 2; Differentiation; Glioma; PPAR ; PTEN

Indexed keywords

CELL DIFFERENTIATION AGENT 2; CYCLOOXYGENASE 2; GLIAL FIBRILLARY ACIDIC PROTEIN; NATURAL PRODUCT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; GLIOMA; HUMAN; HUMAN CELL; PROTEIN FUNCTION; PROTEIN STRUCTURE; RECEPTOR UPREGULATION;

ANALYSIS OF VARIANCE; ANILIDES; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SIZE; CELL SURVIVAL; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FLOW CYTOMETRY; GLIOMA; HUMANS; PEPTIDES; PHENYLACETATES; PPAR GAMMA; TIME FACTORS;

EID: 70349308639     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-9900-x     Document Type: Article

References (38)

1. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-225 (discussion 226-219, 2002)
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996. doi: 10.1056/ NEJMoa043330
3. Leszczyniecka M, Roberts T, Dent P, Grant S, Fisher PB (2001) Differentiation therapy of human cancer: Basic science and clinical applications. Pharmacol Ther 90:105-156. doi: 10.1016/ S0163-7258(01)00132-2
4. Wang ZY, Chen Z (2000) Differentiation and apoptosis induction therapy in acute promyelocytic leukaemia. Lancet Oncol 1:101-106. doi: 10.1016/ S1470-2045(00)00017-6
5. Kinjo K, Kizaki M, Muto A, Fukuchi Y, Umezawa A, Yamato K, Nishihara T, Hata J, Ito M, Ueyama Y, Ikeda Y (2000) Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice. Leukemia 14:431-438. doi: 10.1038/sj.leu.2401646
6. Wang HY, Zhong XY, Tu YS, Liu ZZ (2006) Effect of CDA-II on the differentiation and inhibition of human glioma cell lines SWO-38. Chin Pharm Bull 22:184-188
7. Yao CJ, Lai GM, Chan CF, Yang YY, Liu FC, Chuang SE (2005) Differentiation of pheochromocytoma PC12 cells induced by human urine extract and the involvement of the extracellular signal-regulated kinase signaling pathway. J Altern Complement Med 11:903-908. doi: 10.1089/ acm.2005.11.903
8. Xin Y, Xu KS (2001) HPLC determination of peptide's molecular weight in Niaoduosuantai (CDA-II) injection. Chin J Pharm Anal 21:191-193
9. Warrell RP Jr, Frankel SR, Miller WH Jr, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A et al (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324:1385-1393
10. Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87:159-170. doi: 10.1016/S0092-8674(00)81333-1
11. Sarraf P, Mueller E, Smith WM, Wright HM, Kum JB, Aaltonen LA, de la Chapelle A, Spiegelman BM, Eng C (1999) Loss-of-function mutations in PPAR gamma associated with human colon cancer. Mol Cell 3:799-804. doi: 10.1016/S1097-2765(01)80012-5
12. Mossner R, Schulz U, Kruger U, Middel P, Schinner S, Fuzesi L, Neumann C, Reich K (2002) Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma. J Invest Dermatol 119:576-582. doi: 10.1046/j.1523-1747.2002.01861.x
13. Yang WL, Frucht H (2001) Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells. Carcinogenesis 22:1379-1383. doi: 10.1093/carcin/22.9.1379
14. Zang C, Liu H, Posch MG, Waechter M, Facklam M, Fenner MH, Ruthardt M, Possinger K, Phillip Koeffler H, Elstner E (2004) Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia. Leuk Res 28:387-397. doi: 10.1016/j.leukres.2003.07.005
15. Ding Q, Jin T, Wang Z, Chen Y (2007) Catalase potentiates retinoic acid-induced THP-1 monocyte differentiation into macrophage through inhibition of peroxisome proliferator-activated receptor gamma. J Leukoc Biol 81:1568-1576. doi: 10.1189/jlb.1106672
16. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK (1998) The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391:79-82. doi: 10.1038/34178
17. Spiegelman BM, Hu E, Kim JB, Brun R (1997) PPAR gamma and the control of adipogenesis. Biochimie 79:111-112. doi: 10.1016/S0300-9084(97)81500-3
18. Grimaldi PA, Teboul L, Inadera H, Gaillard D, Amri EZ (1997) Trans-differentiation of myoblasts to adipoblasts: Triggering effects of fatty acids and thiazolidinediones. Prostaglandins Leukot Essent Fatty Acids 57:71-75. doi: 10.1016/S0952-3278(97)90495-6
19. Rivier M, Safonova I, Lebrun P, Griffiths CE, Ailhaud G, Michel S (1998) Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes. J Invest Dermatol 111:1116-1121. doi: 10.1046/j.1523-1747.1998.00439.x
20. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM (1998) PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93:241-252. doi: 10.1016/S0092-8674(00)81575-5
21. Zander T, Kraus JA, Grommes C, Schlegel U, Feinstein D, Klockgether T, Landreth G, Koenigsknecht J, Heneka MT (2002) Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma. J Neurochem 81:1052-1060. doi: 10.1046/j.1471-4159.2002.00899.x
22. Situ R, Wang HH, Wang JH, He LP, Zhu XL, Ou WF (1987) Establishement of human brain malignant glioma cell line(SWO-38) and observation of its biologic properties. Chin J Cancer 6:235-238
23. Roymans D, Vissenberg K, De Jonghe C, Grobben B, Claes P, Verbelen JP, Van Broeckhoven C, Slegers H (2001) Phosphatidylinositol 3-kinase activity is required for the expression of glial fibrillary acidic protein upon cAMP-dependent induction of differentiation in rat C6 glioma. J Neurochem 76:610-618. doi: 10.1046/j.1471-4159.2001.00077.x
24. Elnemr A, Ohta T, Iwata K, Ninomia I, Fushida S, Nishimura G, Kitagawa H, Kayahara M, Yamamoto M, Terada T, Miwa K (2000) PPARgamma ligand (thiazolidinedione) induces growth arrest and differentiation markers of human pancreatic cancer cells. Int J Oncol 17:1157-1164
25. Elstner E, Muller C, Koshizuka K, Williamson EA, Park D, Asou H, Shintaku P, Said JW, Heber D, Koeffler HP (1998) Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc Natl Acad Sci USA 95:8806-8811. doi: 10.1073/ pnas.95.15.8806
26. Laidler P, Dulinska J, Mrozicki S (2007) Does the inhibition of c-myc expression mediate the anti-tumor activity of PPAR's ligands in prostate cancer cell lines? Arch Biochem Biophys 462:1-12. doi: 10.1016/ j.abb.2007.03.013
27. Cimini A, Cristiano L, Colafarina S, Benedetti E, Di Loreto S, Festuccia C, Amicarelli F, Canuto RA, Ceru MP (2005) PPARgamma-dependent effects of conjugated linoleic acid on the human glioblastoma cell line (ADF). Int J Cancer 117:923-933. doi: 10.1002/ijc.21272
28. Bocca C, Bozzo F, Francica S, Colombatto S, Miglietta A (2007) Involvement of PPAR gamma and E-cadherin/beta-catenin pathway in the antiproliferative effect of conjugated linoleic acid in MCF-7 cells. Int J Cancer 121:248-256. doi: 10.1002/ijc.22646
29. Zheng H, Ying H, Yan H, Kimmelman AC, Hiller DJ, Chen AJ, Perry SR, Tonon G, Chu GC, Ding Z, Stommel JM, Dunn KL, Wiedemeyer R, You MJ, Brennan C, Wang YA, Ligon KL, Wong WH, Chin L, DePinho RA (2008) p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature 455:1129-1133. doi: 10.1038/nature07443
30. Lu S, Yu G, Zhu Y, Archer MC (2005) Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation. Int J Cancer 116:847-852. doi: 10.1002/ijc.21142
31. Shono T, Tofilon PJ, Bruner JM, Owolabi O, Lang FF (2001) Cyclooxygenase-2 expression in human gliomas: Prognostic significance and molecular correlations. Cancer Res 61:4375-4381
32. Patel L, Pass I, Coxon P, Downes CP, Smith SA, Macphee CH (2001) Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN. Curr Biol 11:764-768. doi: 10.1016/ S0960-9822(01)00225-1
33. Teresi RE, Shaiu CW, Chen CS, Chatterjee VK, Waite KA, Eng C (2006) Increased PTEN expression due to transcriptional activation of PPARgamma by Lovastatin and Rosiglitazone. Int J Cancer 118:2390-2398. doi: 10.1002/ijc.21799
34. Farrow B, Evers BM (2003) Activation of PPARgamma increases PTEN expression in pancreatic cancer cells. Biochem Biophys Res Commun 301:50-53. doi: 10.1016/S0006-291X(02)02983-2
35. Meade EA, McIntyre TM, Zimmerman GA, Prescott SM (1999) Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. J Biol Chem 274:8328-8334. doi: 10.1074/jbc.274.12.8328
36. Subbaramaiah K, Lin DT, Hart JC, Dannenberg AJ (2001) Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300. J Biol Chem 276:12440-12448. doi: 10.1074/jbc.M007237200
37. Kosaka T, Miyata A, Ihara H, Hara S, Sugimoto T, Takeda O, Takahashi E, Tanabe T (1994) Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur J Biochem 221:889-897. doi: 10.1111/j.1432-1033.1994.tb18804.x
38. St-Germain ME, Gagnon V, Parent S, Asselin E (2004) Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway. Mol Cancer 3:7. doi: 10.1186/ 1476-4598-3-7